Build your own keyword analysis with our tools
SEO Report
Server Infos
Backlinks

HTML Analysis

Page Status
 

Found

Highlighted Content
Title

ARIAD Pharmaceuticals, Inc: Home

Description

Our mission is to discover, develop and commercialize small-molecule medicines to treat cancer in patients with the greatest unmet medical need—those with aggressive cancers where current therapies are inadequate. We are committed to the highest standards of integrity and stewardship in service to patients, the medical community, employees and shareholders.

Keywords

cancer medication,reimbursement support,ariad,new medicine,cancer patients,cancer research,clinical trials,medicines

H1

Discovering
Developing
Delivering
Iclusig ® (ponatinib)

H2

Approved in the U.S. & EU: Iclusig ® (ponatinib)
A remarkable place doing remarkable work
A unique, highly targeted approach to cancer
News & Features
Twitter Feed

H3

An ARIAD-developed medicine
ARIAD: dedicated to making a difference for cancer patients
Our research & development program
Latest News
ARIAD PASS ™ Program

H4

H5

Text Analysis

Cloud of Keywords from all content
High relevance
 

ariad

Medium relevance
 

mission vision galleryvideo pass&trade gallery cancer ponatinib

Low relevance
 

pass&trade gallery cancer ponatinib benefitscurrent opportunitieseeoephoto continue highly valuesemployee contactscareersour materialscorporate governanceemail alertsir targeted approach university 13ariad sarah schlesinger board kitproxy award twitter iclusig® rockefeller remarkable valuescompany directorsour destinationour logoour healthcare filingsinvestor locationspressroomgrants donationsphoto galleryiclusigabout iclusigariad ariadour pharmaceuticals leadershipboard professionalspatients trialsinvestorsnews releasesevents presentationsstock informationfinancial trialspublicationsinvestigator-sponsored scienceponatinibap26113clinical informationsec caregiversresearch developmentpipelineour

Very Low relevance
 
benefitscurrent opportunitieseeoephoto continue highly valuesemployee contactscareersour materialscorporate governanceemail alertsir targeted approach university 13ariad sarah schlesinger board kitproxy award twitter iclusig® rockefeller remarkable valuescompany directorsour destinationour logoour healthcare filingsinvestor locationspressroomgrants donationsphoto galleryiclusigabout iclusigariad ariadour pharmaceuticals leadershipboard professionalspatients trialsinvestorsnews releasesevents presentationsstock informationfinancial trialspublicationsinvestigator-sponsored scienceponatinibap26113clinical informationsec caregiversresearch developmentpipelineour @robinroberts inspiring night ashe courage @ariadpharmcongrats perseverance contact arthur treatment comprehensive access patients services program providing agoariadpharmaceuticals learn adhere afford feedariadpharmaceuticals days privacy policy conditions terms rights reserved statement map click cancelcontinue website leaving directions youtube linkedin release http press named announced e5joopewyb2 unionread videos photo tweet share print @ariadpharmjust names medicines patients go differentiated bringing delivering committed internally discovered iclusig approved medicine developed expertise go chemistry medicines go developing rigorous discovering disciplined discovering a definitive clinical biology deep based trials ariad-developed medicine learn features latest news program learn development news7 directorsread authorization marketing announces more7 cancer our unique warning corporate boxed including prescribing video a work ariad patients learn difference making dedicated european

Highlighted Content Analysis

Cloud of Keywords from all content
High relevance
 

Medium relevance
 

ariad patients cancer

Low relevance
 

patients cancer medical program remarkable news ponatinib iclusig medicines

Very Low relevance
 
medical program remarkable news ponatinib iclusig medicines features twitter feed unique highly ariad-developed work approach targeted difference new medicine reimbursement support cancer patients cancer research clinical trials cancer medication &trade making dedicated development latest pass medicine developing unmet greatest need—those aggressive cancers treat small-molecule mission pharmaceuticals discover develop commercialize therapies inadequate employees community shareholders discovering delivering service stewardship committed highest standards integrity approved